Atlas Trials

A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects

Clinical trial NCT02753218 · TERMINATED

Trial details

NCT number
NCT02753218
Sponsor
LEO Pharma
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2016-04-01
Primary completion
2016-05-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.